Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and migraine in healthy volunteers
NL-OMON59277Phase 1Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- May 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 1 trial of oxytocin in migraine, sponsored by Erasmus MC. Planned start May 2025; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
migraine
Beyond the preview
Go deeper on NL-OMON59277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59277.